Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001584624 | SCV001812561 | likely benign | not provided | 2021-10-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276820 | SCV002566346 | uncertain significance | Ehlers-Danlos syndrome | 2019-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488415 | SCV002795087 | likely benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001584624 | SCV004156238 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TNXB: BS2 |
Prevention |
RCV003910912 | SCV004720145 | likely benign | TNXB-related disorder | 2022-02-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |